MeSH term
Frequency | Condition_Probility | Animals | 11 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Humans | 50 | 0.0 |
Mice | 6 | 0.0 |
Phosphorylation | 15 | 0.0 |
Research Support, Non-U.S. Gov't | 42 | 0.0 |
Thymidine Kinase/metabolism | 6 | 20.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Comparative Study | 7 | 0.0 |
Thymidine/*metabolism | 2 | 11.0 |
Sequence Alignment | 3 | 0.0 |
Substrate Specificity | 17 | 0.0 |
Thymidine Kinase/*chemistry | 2 | 50.0 |
In Vitro | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Child, Preschool | 5 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
DNA, Mitochondrial/genetics/*metabolism | 3 | 21.0 |
Female | 11 | 0.0 |
Infant | 3 | 0.0 |
Male | 9 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Point Mutation/*genetics | 2 | 0.0 |
Thymidine Kinase/*genetics/metabolism | 2 | 28.0 |
Blotting, Southern | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Homozygote | 3 | 0.0 |
Pedigree | 2 | 0.0 |
Adult | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Binding Sites | 2 | 0.0 |
Kinetics | 10 | 0.0 |
Stereoisomerism | 2 | 0.0 |
Deoxycytidine Kinase/antagonists & inhibitors/*metabolism | 2 | 100.0 |
Drug Design | 2 | 0.0 |
Leukemia/*enzymology | 3 | 23.0 |
Structure-Activity Relationship | 3 | 0.0 |
Thymidine Kinase/antagonists & inhibitors/*metabolism | 2 | 66.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Deoxycytidine Kinase/*metabolism | 5 | 13.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 3 | 3.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Thymidine Kinase/*metabolism | 5 | 33.0 |
Amino Acid Sequence | 3 | 0.0 |
Antiviral Agents/*metabolism | 2 | 16.0 |
Thymidine Kinase/chemistry/*genetics/metabolism | 2 | 66.0 |
Spleen/enzymology | 3 | 9.0 |
Cells, Cultured | 6 | 0.0 |
Child | 2 | 0.0 |
Gene Expression Regulation, Enzymologic/drug effects | 2 | 1.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Lymphocytes/*enzymology | 2 | 2.0 |
English Abstract | 2 | 0.0 |
Thymidine/metabolism | 2 | 0.0 |
Deoxycytidine/metabolism | 3 | 37.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Thymidine Kinase/*genetics | 2 | 4.0 |
Cattle | 3 | 0.0 |
Mitochondria/enzymology | 3 | 2.0 |
Thymidine Kinase/isolation & purification/*metabolism | 2 | 100.0 |
Radioisotope Dilution Technique | 2 | 6.0 |
Tritium | 2 | 0.0 |
Cladribine/metabolism | 2 | 66.0 |
Models, Chemical | 2 | 0.0 |
Leukocytes, Mononuclear/*enzymology | 2 | 8.0 |
Thymine Nucleotides/pharmacology | 2 | 33.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Middle Aged | 3 | 0.0 |
Chromatography, Thin Layer | 2 | 1.0 |
DNA/metabolism | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Rats | 2 | 0.0 |
T-Lymphocytes/*drug effects/enzymology | 2 | 20.0 |
Binding, Competitive | 2 | 0.0 |
Deoxyribonucleotides/*metabolism | 3 | 60.0 |
DNA, Mitochondrial/*metabolism | 2 | 15.0 |
Mutation | 3 | 0.0 |
Adenosine Triphosphate/metabolism | 5 | 1.0 |
Adolescent | 2 | 0.0 |
Deoxyadenine Nucleotides/chemistry/*metabolism | 2 | 66.0 |
Electron Transport Complex IV/metabolism | 3 | 6.0 |
Mitochondria/*metabolism | 2 | 1.0 |
Thymidine Kinase/*deficiency | 2 | 100.0 |
Thymidine Kinase/*blood | 2 | 25.0 |
Lymphocytes/enzymology | 2 | 2.0 |
Cytidine Triphosphate/metabolism | 2 | 33.0 |
